Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Myeloid sarcoma developing in pre-existing pyoderma gangrenosum.

Ida Bruun Kristensen1, Hanne Møller, Mette Wanscher Kjaerskov

  • 1Department of Haematology, Odense University Hospital, Odense C, Denmark. idabk@dadlnet.dk

Acta Dermato-Venereologica
|March 28, 2009
PubMed
Summary

Pyoderma gangrenosum can indicate a serious underlying blood disorder transformation. Re-biopsy of non-healing ulcers is crucial in patients with myelodysplastic syndrome to detect myeloid sarcoma and guide treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Proinflammatory GSDMD activation in live macrophages and DLBCL cells marks cognate interactions and better prognosis.

Blood advances·2025
Same author

Outcome of T-cell/histiocyte-rich large B-cell lymphoma-A Danish nationwide matched cohort study.

British journal of haematology·2025
Same author

Ixazomib treatment has a dual effect on bone remodeling in patients with multiple myeloma: follow-up results from a phase 2 clinical study.

Bone·2025
Same author

A Novel Case of Indolent T-Lymphoblastic Proliferation in Metastatic High-Grade Serous Adenocarcinoma.

International journal of laboratory hematology·2025
Same author

Correction: Ibrutinib as treatment for Bing-Neel syndrome reclassified as glioblastoma: a case report.

Journal of medical case reports·2025
Same author

Monitoring ctDNA in aggressive B-cell lymphoma: a prospective correlative study of ctDNA kinetics and PET-CT metrics.

Blood advances·2025

Area of Science:

  • Hematology
  • Dermatology
  • Oncology

Background:

  • Pyoderma gangrenosum (PG) is a rare, destructive neutrophilic dermatosis.
  • Myelodysplastic syndromes (MDS) are a group of clonal hematopoietic stem cell disorders.
  • Transformation of MDS to acute myeloid leukemia (AML) is a critical clinical event.

Observation:

  • A patient with myelodysplastic syndrome presented with pyoderma gangrenosum.
  • The pyoderma gangrenosum ulcers showed secondary blastic infiltration.
  • This infiltration was indicative of transformation to myeloid sarcoma, a precursor to acute leukemia.

Findings:

  • The patient received intensive chemotherapy.
  • Complete remission of the hematological malignancy was achieved.

Related Experiment Videos

  • Healing of the pyoderma gangrenosum ulcers was observed following treatment.

    • Implications:

    • This case represents the first report of secondary blastic infiltration within pyoderma gangrenosum.
    • It highlights the importance of re-biopsy for non-healing ulcers in patients with hematological diseases.
    • Early detection of myeloid sarcoma through re-biopsy can lead to timely and effective treatment.